AVAH vs NHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AVAH · Aveanna Healthcare$13.25 ▼ 3.07%
NHC · National Healthcare$208.85 ▲ 0.59%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AVAH +48.0%
- NHC +62.1%
Head to head
| Metric | AVAH | NHC |
|---|---|---|
| Price | $13.25 | $208.85 |
| Change today | ▼ 3.07% | ▲ 0.59% |
| Market cap | $2.89B | $3.27B |
| Return, 3 months | +40.1% | -5.2% |
| Return, year to date | +62.2% | +53.9% |
| Return, 1 year | +51.4% | +66.7% |
| P/E (TTM) | 10.5 | 28.9 |
| P/B | 10.0 | 2.9 |
| P/E percentile vs own 5y | 81st | 57th |
| Dividend yield | – | 1.25% |
| Revenue growth (YoY, latest qtr) | +13.7% | +8.8% |
| Net profit growth (YoY) | +49.1% | +68.1% |
| Gross margin | 32.3% | 39.5% |
| Operating margin | 10.8% | 9.3% |
| Net margin | 10.6% | 9.0% |
| Return on equity | 198.6% | 13.1% |
| Analyst target vs. price | +13.2% | – |
| Analyst buy share | 71% | – |
| RSI (14) | 53 | 41 |
| 30-day volatility | 36.3% | 41.7% |
| Max drawdown, 1 year | -36.9% | -18.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NHC is the largest of the group by market value.
- NHC has returned the most over the past year.
- AVAH carries the lowest trailing P/E.
- AVAH is growing revenue fastest.
- AVAH keeps the most profit per dollar of sales.
- AVAH has been the calmest stock over the last 30 days.